Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
116,5% Cutaquig----1件: 65
22(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACID----2件: 19, 65
336-482-Hyaluronoglucosaminidase PH20 (rHuPH20)1件: Hyaluronidase3件: D04455 ,
D04456 ,
D06604 		--1件: 65
4A10BK03----1件: 65
5Abatacept1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300
6Acetyl-l-leucine2件: L-Acetylleucine,
Leucine		1件: D00030 --2件: 19, 65
7Acoziborole1件: Acoziborole---1件: 65
8Acoziborole (SCYX-7158)1件: Acoziborole---1件: 65
9ADA gene transfer----1件: 65
10ADA PBSC----1件: 65
11ADA Umbilical Cord Blood Cells----1件: 65
12Adagen1件: Pegademase1件: D05384 --1件: 65
13Adenosine1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 13, 58, 65
14Administration of drug (Interferon-gamma 1-b) subcutaneously----1件: 65
15Adverse Reactions of Gammagard subcutaneously at Week 12----1件: 65
16Adverse Reactions of Gammagard subcutaneously at Week 24----1件: 65
17Adverse Reactions of Gammagard subcutaneously at Week 36----1件: 65
18Adverse Reactions of Gammagard subdermally at Week 12----1件: 65
19Adverse Reactions of Gammagard subdermally at Week 24----1件: 65
20Adverse Reactions of Gammagard subdermally at Week 36----1件: 65
21ALDESLEUKIN1件: Aldesleukin1件: D00748 3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬4件: 49, 65, 96, 97
22Alefacept1件: Alefacept1件: D02800 1件: CD58 💬2件: Cell adhesion molecules, Epstein-Barr virus infection 💬6件: 37, 60, 65, 164, 284, 285
23ALEMTUZUMAB1件: Alemtuzumab1件: D02802 1件: CD52 💬-17件: 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284
24Alemtuzumab 0.2 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-2件: 65, 164
25Alemtuzumab 0.3 mg1件: Alemtuzumab1件: D02802 1件: CD52 💬-2件: 65, 164
26Allogeneic peripheral blood stem cell----1件: 65
27Anti-CD45----3件: 60, 65, 285
28Anti-Thymocyte Globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285
29Anti-thymocyte globulin (rabbit)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---3件: 60, 65, 285
30AProArt----1件: 65
31Argininhydrochlorid----1件: 65
32ARTEGENE drug product----1件: 65
33Asceniv™----1件: 65
34Asparaginase1件: Asparaginase Escherichia coli---1件: 65
35Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene----1件: 65
36AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR----1件: 65
37Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy----1件: 65
38Autologous CD34+ cells transduced with WASP lentiviral vector----1件: 65
39Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence----1件: 65
40Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene----1件: 65
41AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR----1件: 65
42Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)1件: Adenosine1件: D00045 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 65
43AVTX-803----1件: 65
44AVTX-803 (L-Fucose)1件: Fucose---1件: 65
45Azathioprine1件: Azathioprine1件: D00238 --21件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162
46B-Lymphocyte Stimulator (BLyS)----1件: 65
47Baclofen1件: Baclofen1件: D00241 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206
48Bacteriophage----1件: 65
49Benznidazole1件: Benznidazole1件: D02489 --1件: 65
50Betamethasone1件: Betamethasone1件: D00244 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬8件: 2, 28, 46, 65, 83, 90, 96, 235
51Betamethasone Oral Solution Period 1 and Period 21件: Betamethasone1件: D00244 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
52Betamethasone solution as intramuscular injection Period 1 and Period 21件: Betamethasone1件: D00244 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
53Biological sampling----1件: 65
54Bivigam----1件: 65
55BMS-188667----9件: 46, 49, 53, 65, 96, 97, 107, 222, 271
56BPX-501 T cells----4件: 65, 284, 285, 326
57BT090----1件: 65
58BT524----1件: 65
59BT595----2件: 63, 65
60BT681----1件: 65
61BUSILVEX1件: Busulfan1件: D00248 --4件: 19, 36, 60, 65
62BUSILVEX - 6 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 10 ML 8 FLACONCINI1件: Busulfan1件: D00248 --2件: 19, 65
63Busulfan1件: Busulfan1件: D00248 --13件: 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326
64Busulfan test dose1件: Busulfan1件: D00248 --1件: 65
65Busulfan, Cyclophosphamide, ATG, GCSF2件: Busulfan,
Cyclophosphamide		3件: D00248 ,
D00287 ,
D07760 		--2件: 65, 284
66Busulfan, Fludarabine and ATG2件: Busulfan,
Fludarabine		2件: D00248 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65
67Busulfan, Fludarabine, ATG, TLI2件: Busulfan,
Fludarabine		2件: D00248 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284
68C1 ESTERASE INHIBITOR (HUMAN)1件: Human C1-esterase inhibitor---1件: 65
69C1 Esterase Inhibitor Human1件: Human C1-esterase inhibitor---1件: 65
70C1 inhibitor1件: Human C1-esterase inhibitor---1件: 65
71C1 inhibitor concentrate1件: Human C1-esterase inhibitor---1件: 65
72C1-esterase inhibitor [recombinant] (C1-INH-R)1件: Human C1-esterase inhibitor---1件: 65
73C1-INH1件: Human C1-esterase inhibitor---1件: 65
74Campath1件: Alemtuzumab1件: D02802 1件: CD52 💬-12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326
75Campath -1H1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 65
76Campath 1H1件: Alemtuzumab1件: D02802 1件: CD52 💬-4件: 60, 65, 164, 285
77Campath, Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		3件: D00287 ,
D07760 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284
78Catapresan----2件: 65, 78
79Catapresan 75, Tabletten----1件: 65
80CD3/CD19 neg allogeneic BMT----1件: 65
81CD3/CD19 negative allogeneic hematopoietic stem cells----1件: 65
82CD34 Stem Cell Selection Therapy----3件: 60, 65, 284
83CD34+----1件: 65
84CD34+ cells transduced with ADA retrovir----1件: 65
85CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT----1件: 65
86CD34+CELLS----2件: 65, 285
87CDZ173----2件: 53, 65
88CL20-i4-EF1a-h?c-OPT----1件: 65
89Clonidine1件: Clonidine1件: D00281 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬4件: 6, 65, 70, 78
90Clonidinhydrochlorid----1件: 65
91Collection of samples----4件: 49, 65, 95, 107
92Conjugated pneumococcal vaccine (Prevenar)----1件: 65
93COVID-19 Vaccine Moderna1件: Moderna COVID-19 Vaccine1件: D12114 --4件: 46, 51, 65, 299
94Cryopreserved EFS-ADA LV transduced patient CD34+ cells----1件: 65
95Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells----1件: 65
96Cultured Thymus Tissue----1件: 65
97Cultured Thymus Tissue for Implantation (CTTI)----1件: 65
98Cultured Thymus Tissue Implantation (CTTI)----1件: 65
99CUTAQUIG----1件: 65
100CUVITRU----1件: 65
101Cuvitru 200 mg/ml solution for subcutaneous injection1件: Human immunoglobulin G---1件: 65
102Cyclophosphamide1件: Cyclophosphamide2件: D00287 ,
D07760 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331
103Cyclophosphamide (Cytoxan)1件: Cyclophosphamide2件: D00287 ,
D07760 		--1件: 65
104Cyclophosphamide 301件: Cyclophosphamide2件: D00287 ,
D07760 		--3件: 65, 285, 326
105Cyclophosphamide 401件: Cyclophosphamide2件: D00287 ,
D07760 		--3件: 65, 285, 326
106Cyclophosphamide Dose Level 11件: Cyclophosphamide2件: D00287 ,
D07760 		--2件: 65, 284
107Cyclophosphamide Dose Level 21件: Cyclophosphamide2件: D00287 ,
D07760 		--2件: 65, 284
108Cyclophosphamide Dose Level 31件: Cyclophosphamide2件: D00287 ,
D07760 		--2件: 65, 284
109Cyclophosphamide Dose Level 41件: Cyclophosphamide2件: D00287 ,
D07760 		--2件: 65, 284
110Cyclophosphamide post transplant1件: Cyclophosphamide2件: D00287 ,
D07760 		--1件: 65
111Cyclosporine1件: Cyclosporine1件: D00184 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬37件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302
112Cyclosporins----4件: 53, 60, 65, 222
113Cytarabine1件: Cytarabine1件: D00168 --7件: 11, 13, 14, 25, 49, 60, 65
114DACLIZUMAB1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬8件: 13, 56, 60, 65, 97, 107, 283, 284
115Danazol1件: Danazol1件: D00289 3件: AR,
ESR1,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬5件: 60, 63, 64, 65, 285
116Data collection----1件: 65
117Daunorubicin1件: Daunorubicin1件: D07776 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 65
118DB289----1件: 65
119Depletion in CD45RA graft donor----1件: 65
120Dexametasone Fosfato Sodico----1件: 65
121Dexamethasone1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
122Dexamethasone 21-dihydrogen phosphate3件: Dexamethasone,
Hydrogen,
Phosphate ion		1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
123DEXAMETHASONE SODIUM PHOSPHATE2件: Dexamethasone,
Phosphate ion		1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 65, 70, 96
124Dexamethasone sodium phosphate (soluzione 25mg/ml)2件: Dexamethasone,
Phosphate ion		1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
125DEXAMETHASONE SODIUM PHOSPHATE PH. EUR.2件: Dexamethasone,
Phosphate ion		1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
126Dexamethasone, procarbazine2件: Dexamethasone,
Procarbazine		2件: D00292 ,
D08423 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
127Dextrose1件: Dextrose, unspecified form---4件: 60, 65, 70, 226
128Dextrose, 5% in Water2件: Dextrose, unspecified form,
Water		1件: D00001 --1件: 65
129Dihydrogen1件: Hydrogen---1件: 65
130Donor peripheral blood stem cells.----1件: 65
131Doxorubicin1件: Doxorubicin1件: D03899 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬5件: 26, 28, 34, 65, 331
132Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase4件: Asparaginase Escherichia coli,
Cyclophosphamide,
Doxorubicin,
Methotrexate		4件: D00142 ,
D00287 ,
D03899 ,
D07760 		4件: DHFR,
DHFR2,
TOP2A,
TOP2B 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬1件: 65
133EDS-EP dose range of ~14-22 mg DSP/infusion----1件: 65
134EDS-EP dose range of ~5-10 mg DSP/infusion----1件: 65
135EF1aS-ADA lentiviral vector gene modified autologous CD34+ cells----1件: 65
136EF1aS-ADA lentiviral vector transduced patient CD34+ cells----1件: 65
137Efficacy of Gammagard subcutaneously at Week 12----1件: 65
138Efficacy of Gammagard subcutaneously at Week 24----1件: 65
139Efficacy of Gammagard subcutaneously at Week 36----1件: 65
140Efficacy of Gammagard subdermally at Week 12----1件: 65
141Efficacy of Gammagard subdermally at Week 24----1件: 65
142Efficacy of Gammagard subdermally at Week 36----1件: 65
143Eflornithine1件: Eflornithine1件: D07883 1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65
144Eflornithine plus Nifurtimox combination therapy2件: Eflornithine,
Nifurtimox		2件: D00833 ,
D07883 		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65
145ELTROMBOPAG1件: Eltrombopag---5件: 60, 63, 65, 284, 285
146Emapalumab1件: Emapalumab1件: D11120 1件: IFNG 💬32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬3件: 49, 65, 107
147Emapalumab-Izsg1件: Emapalumab1件: D11120 1件: IFNG 💬32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 65
148Empagliflozin1件: Empagliflozin1件: D10459 1件: SLC5A2 💬-6件: 58, 65, 67, 72, 97, 257
149EP2006----1件: 65
150EP2006 (Filgrastim)1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65
151Estradiol1件: Estradiol1件: D00105 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬7件: 13, 46, 49, 65, 76, 226, 299
152Estradiol valerate2件: Estradiol,
Estradiol valerate		2件: D00105 ,
D01413 		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 65
153Estradiolvalerat----1件: 65
154Etoposide1件: Etoposide1件: D00125 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331
155Etoposide, cytarabine, mercaptopurine3件: Cytarabine,
Etoposide,
Mercaptopurine		4件: D00125 ,
D00161 ,
D00168 ,
D04931 		3件: HPRT1,
TOP2A,
TOP2B 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Platinum drug resistance, Purine metabolism 💬1件: 65
156Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4i-EF1alpha-hgammac-OPT vector----1件: 65
157Ex-vivo gene-therapy----1件: 65
158EZN-2279----1件: 65
159FACS analyses----1件: 65
160Fansidar (pyrimethamine and sulfadoxine)2件: Pyrimethamine,
Sulfadoxine		2件: D00488 ,
D00580 		--1件: 65
161Fexinidazole1件: Fexinidazole1件: D11252 --1件: 65
162Fibrinogen1件: Fibrinogen human---2件: 14, 65
163Fibrinogen (coagulation factorI)1件: Fibrinogen human---1件: 65
164Fibrinogen Concentrate from Human Plasma1件: Fibrinogen human---1件: 65
165Filgrastim1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331
166Filgrastim Hexal1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65
167Filgrastim, Alemtuzumab2件: Alemtuzumab,
Filgrastim		2件: D02802 ,
D03235 		2件: CD52,
CSF3R 💬		-1件: 65
168Fisetin1件: Fisetin---1件: 65
169Flebogamma 5% DIF----1件: 65
170Fludarabina1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 19, 65
171Fludarabina Accord1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65
172FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65
173Fludarabine1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬19件: 11, 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326
174Fludarabine monophosphate1件: Fludarabine1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 65, 284, 326
175Fludarabine phosphate2件: Fludarabine,
Phosphate ion		1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬12件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286
176Fludarabine phosphate 30 mg2件: Fludarabine,
Phosphate ion		1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164
177Fludarabine phosphate 40 mg2件: Fludarabine,
Phosphate ion		1件: D07966 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164
178Fludarabine, Busulfan, Thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Fludarabine		2件: D00248 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65
179Fludarabine, Melphalan, Thiotepa3件: Fludarabine,
Melphalan,
Thiotepa		3件: D00369 ,
D00583 ,
D07966 		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65
180FORTECORTIN----2件: 28, 65
181Fortecortin Inject 40 mg Amp.----1件: 65
182Fucose1件: Fucose---1件: 65
183G-CSF1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬16件: 2, 6, 11, 13, 16, 22, 47, 51, 60, 62, 65, 85, 96, 284, 285, 331
184G-CSF for Conditioning before HSCT.1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65
185G1XCG----1件: 65
186G1XCGD transduced CD34+ cells----1件: 65
187Gadolinium1件: Gadolinium---4件: 13, 34, 46, 65
188Gadolinium For abdomen1件: Gadolinium---1件: 65
189Gadolinium For lower back1件: Gadolinium---1件: 65
190GAMMAGARD LIQUID----1件: 65
191Gammagard S/D (Solvent/Detergent)----1件: 65
192Gammaglobulin----1件: 65
193Gammanorm----2件: 14, 65
194Gammanorm 165 mg/mL----1件: 65
195Gammaplex----2件: 63, 65
196Gammaplex (5%)----1件: 65
197Gammaplex (Intravenous immunoglobulin)----1件: 65
198Gammaplex 101件: Human immunoglobulin G---1件: 65
199GAMUNEX-C----1件: 65
200Gcsf----1件: 65
201Gene sequencing----1件: 65
202Gene therapy----1件: 65
203Gene Therapy Method for CGD----1件: 65
204Gene transduced PBL and/or gene transduced HSC----1件: 65
205Gene-Transduced Autologous CD34+ Stem Cells----1件: 65
206Genetically modified autologous blood stem cells----1件: 65
207Glycolic acid1件: Glycolic acid---1件: 65
208Glycosade----3件: 65, 256, 257
209Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318
210Gp91 Grans----1件: 65
211Granulocyte Colony Stimulating Factor1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬6件: 2, 28, 36, 57, 65, 85
212Granulocyte colony stimulating factor (G-CSF)1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65
213GTG003.08----1件: 65
214GTX-1021件: GTX-102---2件: 65, 201
215GTX-102 high dose fast Period 1 and Period 21件: GTX-102---1件: 65
216GTX-102 low dose fast Period 1 and Period 21件: GTX-102---1件: 65
217GTX-102 medium dose fast Period 1 and Period 21件: GTX-102---1件: 65
218GTX-102 medium dose slow Period 1 and Period 21件: GTX-102---1件: 65
219GVHD Prophylaxis----2件: 60, 65
220Haemocomplettan P----1件: 65
221Haemocomplettan(R) P----1件: 65
222Haemocomplettan(R) P 1g/2g----1件: 65
223Haplo BM with T cell depletion----1件: 65
224Haploidentical Hematopoietic Cell Transplantation----2件: 60, 65
225Hematopoetic Stem Cell Transplantation----5件: 19, 65, 120, 160, 326
226Hematopoietic Stem Cell Transplant----1件: 65
227Hizentra----4件: 14, 50, 51, 65
228Hizentra®1件: Human immunoglobulin G---2件: 14, 65
229HTLP----1件: 65
230HUMAN FIBRINOGEN1件: Fibrinogen human---1件: 65
231Human Fibrinogen Concentrate1件: Fibrinogen human---1件: 65
232Human Immunglobulin G (IgG)----1件: 65
233Human Immunoglobulin----2件: 63, 65
234HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G---4件: 14, 50, 63, 65
235Human normal immunoglobulin1件: Human immunoglobulin G---9件: 11, 13, 14, 43, 45, 50, 51, 63, 65
236HUMAN NORMAL IMMUNOGLOBULIN (IV)1件: Human immunoglobulin G---4件: 11, 14, 63, 65
237Human normal immunoglobulin (IVIg)1件: Human immunoglobulin G---3件: 14, 50, 65
238Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)1件: Human immunoglobulin G---1件: 65
239Human normal immunoglobulin (subcutaneous)1件: Human immunoglobulin G---1件: 65
240HUMAN NORMAL IMMUNOGLOBULIN FOR1件: Human immunoglobulin G---1件: 65
241Human normal immunoglobulin for intravenous administration1件: Human immunoglobulin G---3件: 14, 51, 65
242HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE1件: Human immunoglobulin G---2件: 63, 65
243Human normal immunoglobulin for intravenous use (IVIG)1件: Human immunoglobulin G---1件: 65
244Human normal immunoglobulin for subcutaneous administration1件: Human immunoglobulin G---2件: 51, 65
245Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)1件: Human immunoglobulin G---1件: 65
246Human normal immunoglobulin G (IgG > 98% purity)1件: Human immunoglobulin G---3件: 14, 63, 65
247Human T Lymphoid Progenitor (HTLP) injection----1件: 65
248Hyaluronidase1件: Hyaluronidase3件: D04455 ,
D04456 ,
D06604 		--5件: 14, 28, 51, 65, 331
249Hyaluronoglucosaminidase1件: Hyaluronidase3件: D04455 ,
D04456 ,
D06604 		--1件: 65
250Hydroxyurea1件: Hydroxyurea1件: D00341 1件: RRM2 💬7件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬8件: 3, 13, 19, 20, 65, 85, 86, 284
251HyQvia1件: Hyaluronidase (human recombinant)---2件: 14, 65
252HyQvia 100 mg/ml solution for infusion for subcutaneous use1件: Human immunoglobulin G---1件: 65
253I10E----3件: 14, 63, 65
254IB 1001----1件: 65
255IB1001----2件: 19, 65
256Ibuprofen1件: Ibuprofen1件: D00126 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬7件: 13, 46, 65, 107, 113, 271, 299
257IFN-gamma----1件: 65
258Ig VENA 50 g/l solution for infusion 100 ml vial + infusion set----2件: 63, 65
259IgG Next Generation----2件: 63, 65
260IgG Next Generation (BT595)----1件: 65
261IgHy10----1件: 65
262IGIV, 10%----2件: 14, 65
263IGIV-C 10%----1件: 65
264IgNextGen 16%----1件: 65
265IGNG----1件: 65
266IgPro10----3件: 14, 51, 65
267IgPro20----4件: 14, 50, 51, 65
268IGSC 20%----1件: 65
269IGSC 20% 150 mg/kg----1件: 65
270IGSC 20% daily push versus 2 times per week pump----1件: 65
271IGSC 20% daily push versus every 2 weeks pump----1件: 65
272IGSC 20% daily push versus once a week pump----1件: 65
273IGSC 20% infusion----1件: 65
274IGSC, 16%----1件: 65
275IGSC, 20%----1件: 65
276Immune Globulin Infusion (Human), 10%----1件: 65
277Immune Globulin Intravenous----1件: 65
278Immune Globulin Intravenous (Human)----1件: 65
279Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SN™----1件: 65
280Immune Globulin Intravenous (human), 10%----2件: 14, 65
281Immune Globulin Intravenous (Human), 10% Solution----1件: 65
282Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution----1件: 65
283Immune Globulin Intravenous (IGIV)----1件: 65
284Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified----1件: 65
285Immune Globulin Subcutaneos, 20%1件: Human immunoglobulin G---1件: 65
286Immune Globulin Subcutaneous (Human)----2件: 14, 65
287Immune Globulin Subcutaneous (Human) (SCIG)----1件: 65
288Immune Globulin Subcutaneous (Human), 20%1件: Human immunoglobulin G---1件: 65
289Immune Globulin Subcutaneous (Human), 20% Caprylate/Chromatography Purified (IGSC 20%)----1件: 65
290Immune Globulin Subcutaneous (Human), 20% Solution----1件: 65
291Immune Globulin Subcutaneous (Human), 20%, Caprylate/Chromatography Purified----1件: 65
292Immune Globulin Subcutaneous, 20%1件: Human immunoglobulin G---1件: 65
293Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)----1件: 65
294Immunglobulin (human)----1件: 65
295IMMUNOGLOBULIN G----8件: 2, 11, 13, 14, 49, 50, 63, 65
296Immunoglobulin G (Ig NextGen 16%)----1件: 65
297Immunoglobulin intravenous (human)1件: Human immunoglobulin G---1件: 65
298IMMUNOGLOBULINA UMANA NORMALE----2件: 51, 65
299Immunoglobulins Intravenous (Human)----1件: 65
300Immunoglobulins, normal human----1件: 65
301Immunological diagnosis tests----1件: 65
302Immunosuppression Only Conditioning----1件: 65
303Immunosuppression Only Conditioning -Closed with amendment L----1件: 65
304Increlex1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬4件: 65, 78, 96, 299
305Infliximab1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬26件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271
306Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)----1件: 65
307Infusion of autologous EFS-ADA LV CD34+ cells----1件: 65
308Infusion of lentiviral TYF-CGD-modified autologous stem cells----1件: 65
309INH----1件: 65
310Interferon Gamma1件: Interferon Gamma---8件: 18, 65, 85, 107, 228, 299, 301, 326
311INTERFERON GAMMA-1B2件: Interferon Gamma,
Interferon gamma-1b		1件: D00747 2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326
312Interferon-gamma----1件: 65
313INTERLEUKIN-21件: Human interleukin-2---10件: 2, 35, 49, 50, 53, 55, 65, 96, 97, 162
314Intratect----4件: 13, 14, 35, 65
315Intravenous immunoglobulin infusion----1件: 65
316Intravenous infusion of transduced cells----1件: 65
317Itraconazole1件: Itraconazole1件: D00350 --6件: 3, 46, 65, 96, 227, 299
318IV treatment with IGSC, 10%----1件: 65
319IVIG1件: Human immunoglobulin G---7件: 11, 13, 14, 17, 50, 51, 65
320IVIG-PEG----1件: 65
321Jardiance1件: Empagliflozin1件: D10459 1件: SLC5A2 💬-1件: 65
322JSP191----2件: 65, 285
323Kedrion IVIG 10%----1件: 65
324KIg10----1件: 65
325Kineret1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬9件: 28, 41, 46, 49, 65, 106, 107, 266, 299
326KIOVIG1件: Human immunoglobulin G---2件: 14, 65
327KIOVIG 100 mg/ml solution for infusion1件: Human immunoglobulin G---2件: 14, 65
328KLH----2件: 13, 65
329KVD824----1件: 65
330KVD824 300 mg Compresse a rilascio modificato----1件: 65
331KVD824 300 mg Modified Release Tablets1件: Manganese citrate---1件: 65
332KVD824 hydrochloride----1件: 65
333KVD900----1件: 65
334KVD900 100 mg Film Coated Tablet----1件: 65
335KVD900 300 mg----1件: 65
336KVD900 300 mg Film Coated Tablet----1件: 65
337KVD900 600 mg----1件: 65
338L-Arginin1件: Arginine1件: D02982 --1件: 65
339L-Arginin-hydrochlorid-einmolar Fresenius1件: Arginine1件: D02982 --1件: 65
340L-asparaginase1件: Asparaginase Escherichia coli---1件: 65
341L-fucose1件: Fucose---1件: 65
342LADICell----1件: 65
343Lapine T-Lymphocyte Immune Globulin1件: Antithymocyte immunoglobulin (rabbit)---4件: 62, 65, 283, 286
344Lemtrada1件: Alemtuzumab1件: D02802 1件: CD52 💬-2件: 13, 65
345Leniolisib1件: Leniolisib1件: D11158 3件: PIK3CA,
PIK3CB,
PIK3CD 💬		106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬2件: 53, 65
346Lenograstim1件: Lenograstim1件: D03247 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬7件: 2, 13, 16, 18, 19, 57, 65
347Lentiviral Gene Transfer----1件: 65
348Lentiviral vector transduced CD34+ cells----1件: 65
349Leucine1件: Leucine1件: D00030 --6件: 6, 19, 65, 283, 284, 299
350LFB-IgSC----1件: 65
351MabThera1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271
352MABTHERA - 2 FIALE 100 MG 10 ML1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 19, 65
353Mavorixafor----1件: 65
354MBM-01----1件: 65
355MCTLs----1件: 65
356Melarsoprol1件: Melarsoprol1件: D00832 --1件: 65
357Melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d2件: Eflornithine,
Melarsoprol		2件: D00832 ,
D07883 		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65
358Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d2件: Melarsoprol,
Nifurtimox		2件: D00832 ,
D00833 		--1件: 65
359Melphalan1件: Melphalan1件: D00369 --15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
360Mercaptopurine1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬4件: 65, 96, 97, 164
361Mesna1件: Coenzyme M---10件: 11, 13, 44, 45, 51, 60, 65, 85, 96, 164
362Metformin1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
363Methotrexate1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331
364Methylprednisolone1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296
365Methylprednisolone or Prednisolone2件: Methylprednisolone,
Prednisolone		2件: D00407 ,
D00472 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
366MMF----16件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 107, 162, 222, 224, 226, 299
367Mozobil1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬3件: 19, 65, 285
368MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 24 MG/1.2 ML 1 FLACONCINO1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
369Mozobil 20mg/mL vial (injectable solution for subcutaneous use)1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
370Mozobil 20mg/mL vial (injectable solution, subcutaneous use)1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
371Mozobil,1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
372Mycophenolate1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬36件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300
373Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300
374Mycophenolate mofetil (MMF)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬7件: 13, 49, 51, 60, 65, 66, 222
375Myeloablative Conditioning-Closed with amendment L----1件: 65
376Myeloablative Preparative Regimen----3件: 62, 65, 284
377MYELOSTIM----1件: 65
378MYELOSTIM - 34 1 FLACONCINO LIOFILIZZATO 33.6 MIU + SIRINGA PRERIEMPITA SOLVENTE 1 ML----2件: 19, 65
379MYELOSTIM 34 milions UI/ml - powder and solvent for solution for injection/infusion----1件: 65
380MYELOSTIM 34 milions UI/ml, powder and solvent for solution for injection or infusion----1件: 65
381N-Acetyl-L-Leucine2件: L-Acetylleucine,
Leucine		1件: D00030 --2件: 19, 65
382Nanogam 100 mg/ml----1件: 65
383Nanogam® 50 mg/ml----1件: 65
384NDV-3A----1件: 65
385NewGam----3件: 14, 63, 65
386Newnorm----1件: 65
387Nifurtimox1件: Nifurtimox1件: D00833 --1件: 65
388Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d2件: Eflornithine,
Nifurtimox		2件: D00833 ,
D07883 		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65
389Nifurtimox-Eflronithine Combination Treatment (NECT)1件: Nifurtimox1件: D00833 --1件: 65
390None----20件: 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337
391Normal human immunoglobulin G1件: Human immunoglobulin G---1件: 65
392Norovirus -specific T-cell (NST) therapy----1件: 65
393Noxafil1件: Posaconazole1件: D02555 --3件: 60, 65, 299
394Noxafil 40 mg/ml oral solution1件: Posaconazole1件: D02555 --1件: 65
395NutropinAq 10mg/2ml (30 I.E.) Injektionsllösung1件: Somatotropin---1件: 65
396OCTA-C1-INH1件: Human C1-esterase inhibitor---1件: 65
397Octagam----2件: 13, 65
398Octagam 10%----3件: 50, 63, 65
399Octagam 5%----2件: 13, 65
400OCTAGAM 50 mg/ml oldatos infúzió----1件: 65
401Octanorm----2件: 50, 65
402Octanorm 16.5%----2件: 50, 65
403OMALIZUMAB1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬7件: 46, 53, 65, 98, 162, 226, 299
404Omalizumab (Xolair)1件: Omalizumab1件: D05251 1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 65
405OpenBiome FMT product FMP250----1件: 65
406ORENCIA1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬14件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271
407ORENCIA® 125 mg solution for injection in pre-filled syringe1件: Abatacept1件: D03203 2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 65
408Other hematological Agents----1件: 65
409OTL-101----1件: 65
410OTL-103----1件: 65
411OTL-103 Dispersion for Infusion----1件: 65
412OVASTAT1件: Treosulfan1件: D07253 --2件: 13, 65
413Ovastat 10001件: Treosulfan1件: D07253 --2件: 13, 65
414Ovastat 1000 (Treosulfan injection)1件: Treosulfan1件: D07253 --1件: 65
415Ovastat 1000 mg, powder for solution for infusion1件: Treosulfan1件: D07253 --1件: 65
416Ovastat 50001件: Treosulfan1件: D07253 --2件: 13, 65
417Ovastat 5000 (Treosulfan injection)1件: Treosulfan1件: D07253 --1件: 65
418Ovastat 5000 mg, powder for solution for infusion1件: Treosulfan1件: D07253 --1件: 65
419Palifermin1件: Palifermin1件: D05338 1件: FGFR2 💬13件: Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬5件: 13, 36, 38, 39, 65
420Pantoprazole1件: Pantoprazole1件: D05353 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 13, 65
421Pantoprazolo 20 mg gastro-resistant tablets----1件: 65
422PCCLchimGp91s lentiviral vector transduced CD34+ cells infusion----1件: 65
423PEG----15件: 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337
424Peg-Ada----1件: 65
425PEG-interleukin-21件: Human interleukin-2---1件: 65
426Pentamidine1件: Pentamidine1件: D08333 --2件: 61, 65
427Peripheral Blood Stem Cells----2件: 51, 65
428PHA-022121----1件: 65
429PHA-022121 high dose----1件: 65
430PHA-022121 low dose----1件: 65
431PHA-022121 medium dose----1件: 65
432PHA-022121 selected dose----1件: 65
433Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells----1件: 65
434Pheripheral blood stem cells----1件: 65
435Phosphate1件: Phosphate ion---32件: 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
436PHVS416----1件: 65
437PID----1件: 65
438Pioglitazone1件: Pioglitazone1件: D08378 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
439PLERIXAFOR1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬4件: 20, 65, 285, 299
440Plerixafor for Conditioning before HSCT.1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
441PnCJ PPS----1件: 65
442PNEUMO 23----1件: 65
443Pneumovax® (pneumococcal polysaccharide vaccine)----1件: 65
444Polyclonal IgG----1件: 65
445Polymerase chain reaction----2件: 65, 285
446Posaconazole1件: Posaconazole1件: D02555 --3件: 60, 65, 299
447Posaconazole (PSZ)1件: Posaconazole1件: D02555 --1件: 65
448PPS----1件: 65
449PREDNISOLONE1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
450Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
451PREVENAR----1件: 65
452Prevenar® (7-valent pneumococcal conjugate vaccine)----1件: 65
453PRIVIGEN1件: Human immunoglobulin G---4件: 11, 14, 51, 65
454Privigen®1件: Human immunoglobulin G---3件: 14, 63, 65
455Procarbazine1件: Procarbazine1件: D08423 --1件: 65
456Progynova 21 mite----1件: 65
457Proleukin1件: Aldesleukin1件: D00748 3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬3件: 2, 49, 65
458PROLEUKIN® S1件: Aldesleukin1件: D00748 3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 65
459Promacta1件: Eltrombopag---2件: 63, 65
460Prometic's Immune Globulin Intravenous 10%----1件: 65
461PSRS11.EFS.IL2RG.pre* retroviral vector----1件: 65
462PSRS11.EFS.IL2RG.pre* retroviral vector transduce----1件: 65
463PSRS11.EFS.IL2RG.pre* retroviral vector transduced cells----1件: 65
464PTH----2件: 65, 235
465PTH 1-341件: Teriparatide1件: D06078 1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬2件: 65, 235
466Purified Vero Cell Vaccine)----1件: 65
467PYRIMETHAMINE1件: Pyrimethamine1件: D00488 --4件: 2, 4, 19, 65
468R-hIL-18BP----1件: 65
469Rabbit1件: Rabbit---8件: 11, 13, 49, 51, 60, 65, 96, 285
470Rabbit anti-thymocyte globulin1件: Rabbit---1件: 65
471RAG1 LV CD34+ cells----1件: 65
472Ranitidine1件: Ranitidine1件: D00422 1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬2件: 13, 65
473Recombinant human hyaluronidase2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: D04455 ,
D04456 ,
D06604 		--3件: 14, 28, 65
474Recombinant Human Hyaluronidase (rHuPH20)1件: Hyaluronidase (human recombinant)---1件: 65
475Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV)1件: Hyaluronidase (human recombinant)---1件: 65
476Recombinant human hyaluronidase + immune globulin intravenous1件: Hyaluronidase (human recombinant)---1件: 65
477Reduced Intensity Conditioning----2件: 19, 65
478Reduced Intensity Preparative Regimen----3件: 62, 65, 284
479Reduced Toxicity Ablative Regimen----3件: 62, 65, 284
480Release1件: Manganese citrate---12件: 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299
481Retroviral SF71-gp91phox transduced CD34+ cells----1件: 65
482RhuCD40L----1件: 65
483RI-002----1件: 65
484Rifaximin1件: Rifaximin1件: D02554 --8件: 6, 65, 93, 96, 97, 99, 296, 299
485Rimiducid1件: Rimiducid1件: D11195 1件: CASP9 💬35件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬6件: 19, 60, 65, 284, 285, 326
486RITUXIMAB1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
487Rituximab (RTX) and Azathioprine (AZA)2件: Azathioprine,
Rituximab		2件: D00238 ,
D02994 		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 65
488Romiplostim1件: Romiplostim1件: D08990 1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬4件: 60, 63, 64, 65
489RP-L201----1件: 65
490RTX----5件: 11, 46, 65, 222, 240
491Ruxolitinib1件: Ruxolitinib1件: D09959 2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬3件: 60, 65, 228
492SC treatment with IGSC, 10% with rHuPH20 followed by IV/IGSC, 10% only (safety)----1件: 65
493SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety)----1件: 65
494SCID screening----1件: 65
495SCYX-7158----1件: 65
496Sebetralstat----1件: 65
497Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre----1件: 65
498Sirolimus1件: Sirolimus1件: D00753 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬35件: 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 98, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 300, 331
499Somatic gene-therapy by X-CGD----1件: 65
500Somatotropin1件: Somatotropin---4件: 3, 65, 78, 236
501Somatropin1件: Somatotropin---19件: 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
502Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate5件: Arginine,
Clonidine,
Estradiol,
Estradiol valerate,
Somatotropin		4件: D00105 ,
D00281 ,
D01413 ,
D02982 		5件: ADRA2A,
ADRA2B,
ADRA2C,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Neuroactive ligand-receptor interaction, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway, cGMP-PKG signaling pathway 💬1件: 65
503STA-5326----2件: 65, 96
504Stelara (ustekinumab)1件: Ustekinumab1件: D09214 3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 65
505Stem Cell Transplant----2件: 60, 65
506Stem Cell Transplantation----10件: 13, 19, 20, 46, 65, 90, 125, 164, 234, 326
507STRIMVELIS----1件: 65
508Subcuvia----3件: 14, 49, 65
509Subgam----1件: 65
510Sulfadoxine1件: Sulfadoxine1件: D00580 --1件: 65
511Suspension of autologous CD34+cells transduced with the G1XCGD viral vector----1件: 65
512T-Cell Depleted & CD34+Select/w/StemCell Enriched Product----1件: 65
513Tabelecleucel1件: Tabelecleucel1件: D11146 --1件: 65
514Tablets Fexinidazole1件: Fexinidazole1件: D11252 --1件: 65
515Tacrolimus1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
516Tacrolimus (Tacro)1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 65
517TADEKINIG ALFA1件: Tadekinig alfa---1件: 65
518TAK-771----2件: 14, 65
519Target Sequencing by NGS ( Next-generation sequencing)----1件: 65
520TBX-1400----1件: 65
521Thalidomide1件: Thalidomide1件: D00754 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬20件: 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331
522Therapeutic Allogeneic Lymphocytes----3件: 60, 65, 285
523There is no recommended INN----1件: 65
524Thiotepa1件: Thiotepa1件: D00583 --12件: 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285
525Thiotepa--escalated dose1件: Thiotepa1件: D00583 --4件: 19, 20, 65, 284
526Thiotepa--single daily dose1件: Thiotepa1件: D00583 --4件: 19, 20, 65, 284
527Thymafalsin----1件: 65
528THYMALFASIN1件: Thymalfasin1件: D06116 --1件: 65
529Thymoglobulin1件: Antithymocyte immunoglobulin (rabbit)---7件: 36, 51, 60, 65, 96, 285, 326
530Thymus Tissue for Transplantation----1件: 65
531Thymus/Parathyroid Transplantation----2件: 65, 235
532To be confirmed----3件: 46, 65, 97
533Tociluzumab----1件: 65
534Tofacitinib1件: Tofacitinib1件: D09970 4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
535Total Body Irradiation----1件: 65
536Traditional treatment of CGD and TB----1件: 65
537Transduced Lymphocytes----1件: 65
538Transduced patient CD34+ cells----1件: 65
539Transplant Conditioning with Mobilization and Alemtuzumab1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 65
540Transplant Conditioning with Mobilization Only----1件: 65
541Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan4件: Alemtuzumab,
Fludarabine,
Melphalan,
Thiotepa		4件: D00369 ,
D00583 ,
D02802 ,
D07966 		2件: CD52,
RRM1 💬		7件: , Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164
542TREOSULFAN1件: Treosulfan1件: D07253 --6件: 13, 19, 62, 65, 283, 286
543Triheptanoin1件: Triheptanoin1件: D11465 --10件: 2, 8, 65, 149, 156, 248, 256, 257, 317, 324
544TYF-ADA gene-modified autologous stem cells----1件: 65
545TYF-IL-2Rg gene-modified autologous stem cells----1件: 65
546Unrelated BM with T cell depletion----1件: 65
547Unrelated cord blood----1件: 65
548Ustekinumab1件: Ustekinumab1件: D09214 3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬16件: 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
549Valacyclovir1件: Valaciclovir2件: D08664 ,
D10518 		--1件: 65
550Valproic Acid1件: Valproic acid1件: D00399 7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬7件: 3, 5, 26, 65, 90, 222, 256
551Verorab® (PVRV----1件: 65
552Vigantol----4件: 13, 65, 96, 97
553Vinblastine1件: Vinblastine1件: D08675 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 34, 65
554Vinblastine, vincristine, prednisone, daunorubicin4件: Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		4件: D00473 ,
D07776 ,
D08675 ,
D08679 		12件: NR3C1,
TOP2A,
TOP2B,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Platinum drug resistance, Prion disease, Salmonella infection 💬1件: 65
555Vincristine1件: Vincristine1件: D08679 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬4件: 26, 34, 65, 331
556Vitamin D31件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬12件: 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299
557Vivaglobin----2件: 14, 65
558VM106----1件: 65
559Water1件: Water1件: D00001 --21件: 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299
560Whole Exome Sequencing----3件: 65, 120, 149
561X vivo gene therapy----1件: 65
562X4P-001----1件: 65
563XELJANZ (tofacitinib)1件: Tofacitinib1件: D09970 4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 65
564Xifaxan1件: Rifaximin1件: D02554 --2件: 65, 94
565Zadaxin----2件: 65, 299
566ZARZIO1件: Filgrastim1件: D03235 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬3件: 38, 65, 285
567Zoledronate1件: Zoledronic acid2件: D01968 ,
D08689 		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 46, 65